https://www.selleckchem.com/pr....oducts/deruxtecan.ht
Delta-24-RGD, an oncolytic adenovirus, shows promise against glioblastoma. To enhance virus delivery, we recently demonstrated that human bone marrow-derived mesenchymal stem cells loaded with Delta-24-RGD (hMSC-D24) can eradicate glioblastomas in mouse models. There are no studies examining the safety of endovascular selective intra-arterial (ESIA) infusions of MSC-D24 in large animals simulating human clinical situations. To perform canine preclinical studies testing the feasibility and safety of delivering increasing doses of hMSC
Like
Comment
Share
